EP Lab Digest

#

DIGITAL EDITION

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »

CLINICAL EVENTS CALENDAR

  • Saturday, November 8, 2008 - 15:00
    The American Heart Association Scientific Sessions
    http://www.scientificsessions.org
  • Wednesday, November 19, 2008 - 00:00
    Brisbane, Australia
    http://www.aameda.org
  • Friday, November 21, 2008 - 00:00
    EnSite 3D Mapping System Workshop
    http://www.tcainstitute.com
  • Thursday, November 27, 2008 - 15:00
    1st Asia-Pacific Heart Rhythm Society Scientific Session (APHRS 2008)
    http://www.aphrs2008.com


practical EP

Author Instructions

 

EP Lab Digest will consider for publication suitable articles on topics of interest to electrophysiology laboratory physicians and allied professionals. All articles must be authored or co-authored by a medical clinician.

Manuscripts. All submissions for consideration should be sent to:

Jodie Elrod, Managing Editor
EP Lab Digest
4502 Thorncroft Avenue
Royal Oak, MI 48073
TEL. (800) 371-0791 FAX: (248) 549-1472
Email: jelrod@hmpcommunications.com

Editorial Policies. The statements and opinions expressed in the articles and communications herein are those of the author(s) and not necessarily those of the publisher or editors. All manuscripts submitted for publication must include the following statement signed by the senior author. “The undersigned author transfers all copyright ownership of the manuscript entitled (title of article) to HMP Communications in the event the work is published. The undersigned author warrants that the article is original, is not under consideration by another journal, and has not been previously published. I sign for and accept responsibility for releasing this materi•al on behalf of any and all co-authors.”

Review. In some instances, articles may be peer-reviewed by members of the EP Lab Digest editorial board. Editorial revisions may be made to articles accepted for publication as an aid to clarity.

Conflict of Interest.
A statement acknowledging financial interest in products/companies relevant to submitted research must be dis•closed to the editors when the paper is submitted. Any financial interest which may be interpreted as a conflict of interest, including stock ownership, consultancies, patent-licensing relationships, and other equity interests, must be disclosed in the cover letter. If no conflicts of interest exist, please state this.
Format. The original copy of the article and all supporting material must be submitted to the Editor.

• Please type the manuscript on 8 1 ⁄ 2 x 11 inch paper.

• Double-space the paper, including quotations, footnotes, references, legends, and tables. Do not place figures in Word document; please send them separately in their original TIFF or JPEG file(s).

• Please include a computerized version of the manuscript as well; can be submitted either on CD or sent to the email address listed above.

• Title page. Include the manuscript’s title, name(s) of author(s), and titles of author(s) and the institution at which the work was performed.

• Include the name, complete mailing address, phone and fax numbers, and email address of the author to whom correspondence, proofs, and reprint requests should be directed.

• If applicable, include a brief acknowledgment of grants or of other assistance. Authors should report equity positions in a separate letter. Any relevant financial interests that may be interpreted as a conflict of interest must be acknowledged.

Text.
• Number pages consecutively at the top right corner of the page.

• Indent new paragraphs and skip 1 line between paragraphs.

• Use abbreviations only if they are previously spelled out in the text.

• Use generic drug names (even if trade names are mentioned).

• Obtain appropriate consent for quotations of more than 50 words. Consult The Chicago Manual of Style, 14th Edition for current usage.

Figures/Legends.
• Photographs may be in color or in black & white.

• Photographs must be in high resolution (at least 300 dpi) and in TIFF or JPEG format. Please do not attach figures to a Microsoft Word document; please send separately.

• On the back of each figure affix a gummed label on which the figure number, short article title and top of figure is identified.

• A descriptive legend must accompany each figure or illustration.

• All abbreviations must be identified at the end of the figure legend.

• If the figure has been published previously, permission to reprint the figure must be obtained in writing from the copyright owner and submitted with the manuscript.

References. References should be listed at the end of the manuscript. Numbered references must be cited, in order in the text. A complete periodical reference includes 1) authors’ names (list all authors up to four, for five or more authors, list first three followed
by et al.); 2) title of article; 3) abbreviated journal name; 4) name of publisher; 5) year of publication; 6) volume number; 7) specific
page numbers. For books, please include: 8) name of editor(s), if any; and 9) place of publication.

For example:
Periodical. (List all authors up to 4; for 5 or more authors, list 3 followed by et al.)

8. Waksman R, Carey D, Ghazzal ZMB, King SB III. Coronary excimer laser for unsuccessful angioplasty. J Invas Cardiol 1994;6:21–24.
Book.
5. Rubanyi GD. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. New York: Futura Publishing Co., 1991. Chapter in Book. (Author is not editor of the book)
5. Muller DWM. Restenosis: Site-specific therapy. In: Topol EJ (ed). Textbook of Interventional Cardiology, 2nd edition. Philadelphia: W.B. Saunders Company, 1993: pp. 436–448.
Ethics. The author is responsible for the contents submitted in the paper. Opinions expressed by authors are their own and not neces•sarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. No claims made by authors or advertisers are guaranteed by the publisher or editors. Authors must comply with FDA guidelines, human studies guidelines and animal welfare regulations of the authors’ institution. Authors should indicate in the paper that human subjects have given informed consent and that the authors have conformed to institutional guidelines and those of the American Physiological Society.
Equity Positions. A statement acknowledging financial interest in products/companies relevant to submitted research must be dis•closed to the Editors of EP Lab Digest.

All Subscriptions are FREE to qualified cardiology professionals

#

  • Subscribe to:
  • Journal
  • Digital Journal
  • E-News
  • RSS feed

CLICK HERE TO CONTINUE »

CME Showcase

Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions

Complimentary accredited web archive
This activity is intended for physicians, nurses, and technologists.

Symposium for Advances on
Cardiac Resynchronization Therapy
and Atrial Fibrillation Ablation

Complimentary Accredited Dinner Symposium
This activity has been developed for physicians, nurses, and technologists.
.


Treatment Options for the AF Patient
Complimentary Accredited Dinner Symposium
This activity has been developed for physicians, nurses, and technologists who treat patients with arrythmias.


A-fib Ablation:
Practical Solutions
for the Real World

Complimentary Accredited Lunch Symposium
This activity has been developed for physicians, nurses, and technologists who treat patients with atrial fibrillation.



New Standards of Care for CRMD Antibiotic Protection

Complimentary CME Accredited Webcast

Dates:
November 18, 2008
Time: 6:00 pm ET
November 19, 2008
Time: 3:00 pm ET

This activity is sponsored by the North American Center for Continuing Medical Education.

LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI

Live Symposium

Date: February 26-28
Location: Loews Miami Beach Hotel
Miami Beach, Florida 33139

REVIEW OUR OTHER
CARDIOLOGY BRANDS

Check out our other resources for healthcare professionals of all specialties.
Heart Rhythm

  • Cath Lab Digest
  • Journal Of Invasive Cardiology
  • Vascular Disease Management
  • Cath Lab Basics